JP2024520049A5 - - Google Patents
Info
- Publication number
- JP2024520049A5 JP2024520049A5 JP2023573024A JP2023573024A JP2024520049A5 JP 2024520049 A5 JP2024520049 A5 JP 2024520049A5 JP 2023573024 A JP2023573024 A JP 2023573024A JP 2023573024 A JP2023573024 A JP 2023573024A JP 2024520049 A5 JP2024520049 A5 JP 2024520049A5
- Authority
- JP
- Japan
- Prior art keywords
- endotype
- lgals3bp
- fech
- spred1
- efna1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163192746P | 2021-05-25 | 2021-05-25 | |
| US63/192,746 | 2021-05-25 | ||
| PCT/CA2022/050831 WO2022246553A1 (en) | 2021-05-25 | 2022-05-25 | Diagnostic for sepsis endotypes and/or severity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520049A JP2024520049A (ja) | 2024-05-21 |
| JP2024520049A5 true JP2024520049A5 (enExample) | 2025-06-10 |
Family
ID=84229117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023573024A Pending JP2024520049A (ja) | 2021-05-25 | 2022-05-25 | 敗血症のエンドタイプおよび／または重症度の診断 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240254557A1 (enExample) |
| EP (1) | EP4352250A4 (enExample) |
| JP (1) | JP2024520049A (enExample) |
| CN (1) | CN117751195A (enExample) |
| AU (1) | AU2022283025A1 (enExample) |
| CA (1) | CA3221576A1 (enExample) |
| WO (1) | WO2022246553A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024148050A2 (en) * | 2023-01-04 | 2024-07-11 | Ampel Biosolutions, Llc | Longitudinal gene expression analysis of inflammatory skin diseases |
| EP4766855A1 (en) * | 2023-08-22 | 2026-07-01 | Ramot at Tel-Aviv University Ltd. | SYSTEMIC RESISTANCE AND INFLAMMATION MARKERS AND THEIR USES |
| WO2025090733A1 (en) * | 2023-10-27 | 2025-05-01 | Sanofi | Identifying disease subtypes |
| CN118389664A (zh) * | 2024-04-24 | 2024-07-26 | 南方医科大学深圳医院 | 区分正常患者和脓毒症患者的基因组合物、脓毒症和感染性休克的预测模型的构建方法 |
| CN118621011B (zh) * | 2024-06-18 | 2025-08-29 | 广东医科大学附属医院 | circNfix作为生物标志物在检测、诊断或预后脓毒症急性肾损伤中的应用 |
| CN120939040A (zh) * | 2025-10-20 | 2025-11-14 | 四川省医学科学院·四川省人民医院 | GYG1 siRNA在制备治疗脓毒症的药物中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050196817A1 (en) | 2004-01-20 | 2005-09-08 | Molecular Staging Inc. | Biomarkers for sepsis |
| JP2008538007A (ja) | 2005-04-15 | 2008-10-02 | ベクトン，ディッキンソン アンド カンパニー | 敗血症の診断 |
| DE102005050933A1 (de) * | 2005-10-21 | 2007-04-26 | Justus-Liebig-Universität Giessen | Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen |
| US20110076685A1 (en) | 2009-09-23 | 2011-03-31 | Sirs-Lab Gmbh | Method for in vitro detection and differentiation of pathophysiological conditions |
| US20110312521A1 (en) | 2010-06-17 | 2011-12-22 | Baylor Research Institute | Genomic Transcriptional Analysis as a Tool for Identification of Pathogenic Diseases |
| EP2834638B1 (en) | 2012-04-02 | 2020-02-12 | Astute Medical, Inc. | Methods for diagnosis and prognosis of sepsis |
| EP3013985A4 (en) | 2013-06-28 | 2017-07-19 | Acumen Research Laboratories Pte. Ltd. | Sepsis biomarkers and uses thereof |
| WO2015117204A1 (en) * | 2014-02-06 | 2015-08-13 | Immunexpress Pty Ltd | Biomarker signature method, and apparatus and kits therefor |
| CA2942577A1 (en) | 2014-03-14 | 2015-09-17 | Robert E. W. Hancock | Diagnostic for sepsis |
| CN107532214B (zh) | 2015-03-12 | 2021-08-31 | 斯坦福大学托管董事会 | 用于败血症诊断的方法 |
| GB201518597D0 (en) * | 2015-10-20 | 2015-12-02 | Univ Liverpool | Detection of bacterial infection |
| US11104953B2 (en) * | 2016-05-13 | 2021-08-31 | Children's Hospital Medical Center | Septic shock endotyping strategy and mortality risk for clinical application |
| KR101929772B1 (ko) * | 2016-11-02 | 2018-12-17 | 연세대학교 산학협력단 | 패혈증 진단을 위한 정보를 제공하는 방법 및 이를 이용한 키트 |
| WO2018146162A1 (en) * | 2017-02-07 | 2018-08-16 | Academisch Medisch Centrum | Molecular biomarker for prognosis of sepsis patients |
| US12571044B2 (en) * | 2018-02-27 | 2026-03-10 | The Board Of Trustees Of The Leland Stanford Junior University | Classifier for identification of robust sepsis subtypes |
| US20210388443A1 (en) * | 2018-11-05 | 2021-12-16 | Institute For Systems Biology | Sepsis biomarker panels and methods of use |
-
2022
- 2022-05-25 CN CN202280052217.XA patent/CN117751195A/zh active Pending
- 2022-05-25 JP JP2023573024A patent/JP2024520049A/ja active Pending
- 2022-05-25 WO PCT/CA2022/050831 patent/WO2022246553A1/en not_active Ceased
- 2022-05-25 AU AU2022283025A patent/AU2022283025A1/en active Pending
- 2022-05-25 US US18/563,344 patent/US20240254557A1/en active Pending
- 2022-05-25 EP EP22810003.8A patent/EP4352250A4/en active Pending
- 2022-05-25 CA CA3221576A patent/CA3221576A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12105089B2 (en) | Cell atlas of the healthy and ulcerative colitis human colon | |
| US12421557B2 (en) | Methods for predicting outcomes and treating colorectal cancer using a cell atlas | |
| US12227578B2 (en) | Modulation of intestinal epithelial cell differentiation, maintenance and/or function through T cell action | |
| EP2925885B1 (en) | Molecular diagnostic test for cancer | |
| US10166210B2 (en) | Methods of subtyping CRC and their association with treatment of colon cancer patients with oxaliplatin | |
| US20150315643A1 (en) | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis | |
| US20230340601A1 (en) | Transcriptome Analysis For Treating Inflammation | |
| US20220399116A1 (en) | Systems and methods for assessing a bacterial or viral status of a sample | |
| US11104953B2 (en) | Septic shock endotyping strategy and mortality risk for clinical application | |
| WO2019079647A2 (en) | IA STATISTICS FOR DEEP LEARNING AND PROBABILISTIC PROGRAMMING, ADVANCED, IN BIOSCIENCES | |
| US20110236903A1 (en) | Materials and methods for determining diagnosis and prognosis of prostate cancer | |
| AU2010326066A1 (en) | Classification of cancers | |
| WO2016028638A1 (en) | Methods, computer-readable media, and systems for assessing samples and wounds, predicting whether a wound will heal, and monitoring effectiveness of a treatment | |
| US20250011886A1 (en) | Systems and Methods for Targeting COVID-19 Therapies | |
| US20250388967A1 (en) | Prediction of preeclampsia risk using circulating, cell-free rna | |
| US20240247315A1 (en) | Diagnosing inflammatory bowel diseases | |
| US20250391505A1 (en) | Methods and Systems for Machine Learning Analysis of Lupus Nephritis | |
| Jiang et al. | RNA sequencing data from neutrophils of patients with cystic fibrosis reveals potential for developing biomarkers for pulmonary exacerbations | |
| US20110086342A1 (en) | Hepatocellular Carcinoma-Associated Gene | |
| US20260117297A1 (en) | Longitudinal Gene Expression Analysis of Inflammatory Skin Diseases | |
| US20240229166A9 (en) | Methods of stratifying and treating coronavirus infection | |
| WO2018160880A1 (en) | Compositions and methods for detecting sessile serrated adenomas/polyps | |
| US20170088902A1 (en) | Expression profiling for cancers treated with anti-angiogenic therapy | |
| US20100112568A1 (en) | Methods and kits for diagnosis of multiple sclerosis in probable multiple sclerosis subjects | |
| US20250263792A1 (en) | Methods for the identification and treatment of severe forms of covid-19 |